2011
DOI: 10.1016/j.ejrad.2011.04.041
|View full text |Cite
|
Sign up to set email alerts
|

Gadoxetate disodium-enhanced MR imaging: Differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
3

Year Published

2011
2011
2014
2014

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 20 publications
1
8
3
Order By: Relevance
“…This is in contrast to the recommendations of the consensus report of the Second International Forum for Liver MRI published in 2009 (23). The use of faster, higher spatial resolution 3D pulse sequences is well supported by more recent work from around the world (20,(24)(25)(26)(27)(28). We also noted that although this technique was useful at both 3T and 1.5T, the increased projected energy deposition at 3T (SAR) caused the MR scanner console to reduce the FA of the pulse sequence in four of seven cases performed at 3T in our initial review, a phenomenon that has been previously described (20).…”
Section: Discussioncontrasting
confidence: 51%
“…This is in contrast to the recommendations of the consensus report of the Second International Forum for Liver MRI published in 2009 (23). The use of faster, higher spatial resolution 3D pulse sequences is well supported by more recent work from around the world (20,(24)(25)(26)(27)(28). We also noted that although this technique was useful at both 3T and 1.5T, the increased projected energy deposition at 3T (SAR) caused the MR scanner console to reduce the FA of the pulse sequence in four of seven cases performed at 3T in our initial review, a phenomenon that has been previously described (20).…”
Section: Discussioncontrasting
confidence: 51%
“…In agreement with previous studies (26, 33–35), the vast majority of benign arterial enhancing‐only nodules smaller than 2 cm in our series revealed HP iso‐hyperintensity. Differently from previous studies (36) we only observed 7 benign lesions appearing hypointense on HP which corresponded to high‐flow liver hemangiomas. In any case, the relative prevalence of benign lesions observed is not in agreement with some previous studies which showed that small arterial enhancing‐only nodules, isointense to the liver on T1‐ and T2‐weighted images, are more likely to be HCC in patients with hepatitis B‐related cirrhosis (37).…”
Section: Discussioncontrasting
confidence: 99%
“…In this series, the percentage of HCCs with hepatobiliary phase isohyperintensity (5/57) was low in comparison with previous studies [32], in which about 30% of HCCs revealed iso-or hyperintensity; however, the percentage of dysplastic nodules with hepatobiliary phase hypointensity (2/25) in this study is comparable to that in previous patient series evaluated after gadobenate dimeglumine injection [32]. Other recent studies [33,34] reported an even higher percentage of benign hepatocellular nodules with hepatobiliary phase hypointensity, which was probably due to the use of a different hepatospecific contrast agent (i.e., gadoxetate disodium).…”
Section: Mri Predictors Of Dysplastic Nodule In Patients With Liver Csupporting
confidence: 66%